Log in to search using one of your social media accounts:


The MNI forms promising Open Science partnership with Takeda

(McGill University) A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news

Related Links:

More News: Academia | ALS | Partnerships | Science